annual CFO:
-$113.88M+$22.28M(+16.36%)Summary
- As of today (June 18, 2025), RYTM annual cash flow from operations is -$113.88 million, with the most recent change of +$22.28 million (+16.36%) on December 31, 2024.
- During the last 3 years, RYTM annual CFO has risen by +$32.12 million (+22.00%).
- RYTM annual CFO is now -1532.21% below its all-time high of -$6.98 million, reached on December 31, 2015.
Performance
RYTM Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$40.35M-$21.51M(-114.12%)Summary
- As of today (June 18, 2025), RYTM quarterly cash flow from operations is -$40.35 million, with the most recent change of -$21.51 million (-114.12%) on March 31, 2025.
- Over the past year, RYTM quarterly CFO has increased by +$392.00 thousand (+0.96%).
- RYTM quarterly CFO is now -556.97% below its all-time high of -$6.14 million, reached on June 30, 2017.
Performance
RYTM quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$113.49M+$392.00K(+0.34%)Summary
- As of today (June 18, 2025), RYTM TTM cash flow from operations is -$113.49 million, with the most recent change of +$392.00 thousand (+0.34%) on March 31, 2025.
- Over the past year, RYTM TTM CFO has increased by +$26.98 million (+19.21%).
- RYTM TTM CFO is now -1517.55% below its all-time high of -$7.02 million, reached on March 31, 2017.
Performance
RYTM TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
RYTM Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +16.4% | +1.0% | +19.2% |
| 3 y3 years | +22.0% | +24.8% | +31.7% |
| 5 y5 years | +7.2% | -11.8% | +11.0% |
RYTM Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +34.3% | -114.1% | +24.8% | at high | +36.9% |
| 5 y | 5-year | at high | +34.3% | -114.1% | +24.8% | at high | +36.9% |
| alltime | all time | -1532.2% | +34.3% | -557.0% | +24.8% | -1517.5% | +36.9% |
RYTM Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$40.35M(+114.1%) | -$113.49M(-0.3%) |
| Dec 2024 | -$113.88M(-16.4%) | -$18.84M(-25.3%) | -$113.88M(-8.5%) |
| Sep 2024 | - | -$25.21M(-13.3%) | -$124.42M(-3.1%) |
| Jun 2024 | - | -$29.08M(-28.6%) | -$128.45M(-8.6%) |
| Mar 2024 | - | -$40.74M(+38.7%) | -$140.47M(+3.2%) |
| Dec 2023 | -$136.16M(-21.5%) | -$29.38M(+0.5%) | -$136.16M(-3.3%) |
| Sep 2023 | - | -$29.25M(-28.8%) | -$140.77M(-11.2%) |
| Jun 2023 | - | -$41.09M(+12.8%) | -$158.51M(+1.5%) |
| Mar 2023 | - | -$36.43M(+7.2%) | -$156.23M(-9.9%) |
| Dec 2022 | -$173.43M(+18.8%) | -$34.00M(-27.6%) | -$173.43M(-3.6%) |
| Sep 2022 | - | -$46.99M(+21.1%) | -$179.90M(+3.9%) |
| Jun 2022 | - | -$38.81M(-27.6%) | -$173.07M(+4.2%) |
| Mar 2022 | - | -$53.63M(+32.5%) | -$166.10M(+13.8%) |
| Dec 2021 | -$146.00M(+19.7%) | -$40.47M(+0.8%) | -$146.00M(+8.4%) |
| Sep 2021 | - | -$40.16M(+26.1%) | -$134.65M(+10.8%) |
| Jun 2021 | - | -$31.84M(-5.0%) | -$121.52M(+1.8%) |
| Mar 2021 | - | -$33.53M(+15.1%) | -$119.41M(-2.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | -$121.98M(-0.6%) | -$29.12M(+7.7%) | -$121.98M(-2.5%) |
| Sep 2020 | - | -$27.03M(-9.1%) | -$125.08M(-5.0%) |
| Jun 2020 | - | -$29.73M(-17.6%) | -$131.65M(+3.3%) |
| Mar 2020 | - | -$36.10M(+12.0%) | -$127.47M(+3.8%) |
| Dec 2019 | -$122.75M(+97.8%) | -$32.22M(-4.1%) | -$122.75M(+10.1%) |
| Sep 2019 | - | -$33.60M(+31.5%) | -$111.51M(+17.6%) |
| Jun 2019 | - | -$25.55M(-18.6%) | -$94.85M(+16.0%) |
| Mar 2019 | - | -$31.38M(+49.5%) | -$81.78M(+31.8%) |
| Dec 2018 | -$62.06M(+110.6%) | -$20.98M(+23.9%) | -$62.06M(+26.8%) |
| Sep 2018 | - | -$16.94M(+35.8%) | -$48.96M(+21.1%) |
| Jun 2018 | - | -$12.48M(+7.1%) | -$40.43M(+18.6%) |
| Mar 2018 | - | -$11.65M(+47.8%) | -$34.09M(+15.7%) |
| Dec 2017 | -$29.46M(+26.9%) | -$7.88M(-6.3%) | -$29.46M(+36.5%) |
| Sep 2017 | - | -$8.42M(+37.0%) | -$21.57M(+64.0%) |
| Jun 2017 | - | -$6.14M(-12.5%) | -$13.16M(+87.5%) |
| Mar 2017 | - | -$7.02M | -$7.02M |
| Dec 2016 | -$23.22M(+232.8%) | - | - |
| Dec 2015 | -$6.98M | - | - |
FAQ
- What is Rhythm Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals annual CFO year-on-year change?
- What is Rhythm Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals quarterly CFO year-on-year change?
- What is Rhythm Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals TTM CFO year-on-year change?
What is Rhythm Pharmaceuticals annual cash flow from operations?
The current annual CFO of RYTM is -$113.88M
What is the all time high annual CFO for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high annual cash flow from operations is -$6.98M
What is Rhythm Pharmaceuticals annual CFO year-on-year change?
Over the past year, RYTM annual cash flow from operations has changed by +$22.28M (+16.36%)
What is Rhythm Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of RYTM is -$40.35M
What is the all time high quarterly CFO for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high quarterly cash flow from operations is -$6.14M
What is Rhythm Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, RYTM quarterly cash flow from operations has changed by +$392.00K (+0.96%)
What is Rhythm Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of RYTM is -$113.49M
What is the all time high TTM CFO for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high TTM cash flow from operations is -$7.02M
What is Rhythm Pharmaceuticals TTM CFO year-on-year change?
Over the past year, RYTM TTM cash flow from operations has changed by +$26.98M (+19.21%)